mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-07 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |